The molecular tumor burden index as a response evaluation criterion in breast cancer.
Yi Z, Ma F, Rong G, Liu B, Guan Y, Li J, Sun X, Wang W, Guan X, Mo H, Wang J, Qian H, Xu B.
Yi Z, et al. Among authors: wang w, wang j.
Signal Transduct Target Ther. 2021 Jul 7;6(1):251. doi: 10.1038/s41392-021-00662-9.
Signal Transduct Target Ther. 2021.
PMID: 34230452
Free PMC article.
Clinical Trial.